MBOT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Microbot Medical Inc (MBOT).


$18.96M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

MBOT Market Cap. (MRY)


MBOT Shares Outstanding (MRY)


MBOT Assets (MRY)


Total Assets

$6.03M

Total Liabilities

$2.50M

Total Investments

$2.36M

MBOT Income (MRY)


Revenue

$0

Net Income

-$11.44M

Operating Expense

$11.63M

MBOT Cash Flow (MRY)


CF Operations

-$8.83M

CF Investing

$1.54M

CF Financing

$7.94M

MBOT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

MBOT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$6,031,000 (-27.57%)

$8,327,000 (-12.69%)

$9,537,000 (-43.12%)

$16,767,000 (-36.20%)

Assets Current

$5,819,000 (-26.54%)

$7,921,000 (-10.13%)

$8,814,000 (-44.49%)

$15,879,000 (-37.12%)

Assets Non-Current

$212,000 (-47.78%)

$406,000 (-43.85%)

$723,000 (-18.58%)

$888,000 (-13.45%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$3,530,000 (-21.57%)

$4,501,000 (-38.25%)

$7,289,000 (-49.32%)

$14,381,000 (-40.84%)

Property Plant & Equipment Net

$212,000 (-47.78%)

$406,000 (-43.85%)

$723,000 (-18.58%)

$888,000 (-13.45%)

Cash & Equivalents

$3,163,000 (25.67%)

$2,517,000 (-0.08%)

$2,519,000 (-81.45%)

$13,580,000 (-31.18%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$2,356,000 (-39.85%)

$3,917,000 (-32.03%)

$5,763,000 (188.29%)

$1,999,000 (-60.00%)

Investments Current

$2,356,000 (-39.85%)

$3,917,000 (-32.03%)

$5,763,000 (188.29%)

$1,999,000 (-60.00%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$165,000 (-53.78%)

$357,000 (207.76%)

$116,000 (-58.42%)

$279,000 (1.45%)

Accumulated Retained Earnings (Deficit)

-$90,944,000 (-14.39%)

-$79,501,000 (-15.62%)

-$68,761,000 (-23.69%)

-$55,593,000 (-25.55%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$111,000 (-51.95%)

$231,000 (-50.00%)

$462,000 (-32.06%)

$680,000 (-16.36%)

Debt Current

$70,000 (-63.35%)

$191,000 (-32.51%)

$283,000 (1.80%)

$278,000 (48.66%)

Debt Non-Current

$41,000 (2.50%)

$40,000 (-77.65%)

$179,000 (-55.47%)

$402,000 (-35.78%)

Total Liabilities

$2,501,000 (-34.63%)

$3,826,000 (70.20%)

$2,248,000 (-5.78%)

$2,386,000 (21.06%)

Liabilities Current

$2,460,000 (-35.02%)

$3,786,000 (82.99%)

$2,069,000 (4.28%)

$1,984,000 (47.51%)

Liabilities Non-Current

$41,000 (2.50%)

$40,000 (-77.65%)

$179,000 (-55.47%)

$402,000 (-35.78%)

MBOT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$4,995,000 (20.92%)

$4,131,000 (-25.50%)

$5,545,000 (6.55%)

$5,204,000 (-8.59%)

Research & Development Expense

$6,630,000 (15.83%)

$5,724,000 (-26.01%)

$7,736,000 (25.73%)

$6,153,000 (81.18%)

Operating Expenses

$11,625,000 (17.94%)

$9,857,000 (-25.78%)

$13,281,000 (16.94%)

$11,357,000 (24.95%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$11,443,000 (-6.55%)

-$10,740,000 (18.44%)

-$13,168,000 (-16.40%)

-$11,313,000 (-23.38%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$11,443,000 (-6.55%)

-$10,740,000 (18.44%)

-$13,168,000 (-16.40%)

-$11,313,000 (-23.38%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$11,443,000 (-6.55%)

-$10,740,000 (18.44%)

-$13,168,000 (-16.40%)

-$11,313,000 (-23.38%)

Weighted Average Shares

$15,644,511 (53.38%)

$10,199,984 (40.49%)

$7,260,344 (2.14%)

$7,108,133 (-0.14%)

Weighted Average Shares Diluted

$15,644,511 (53.38%)

$10,199,984 (40.49%)

$7,260,344 (2.14%)

$7,108,133 (-0.14%)

Earning Before Interest & Taxes (EBIT)

-$11,443,000 (-6.55%)

-$10,740,000 (18.44%)

-$13,168,000 (-16.40%)

-$11,313,000 (-23.38%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$11,625,000 (-17.94%)

-$9,857,000 (25.78%)

-$13,281,000 (-16.94%)

-$11,357,000 (-24.95%)

MBOT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$1,537,000 (-22.10%)

$1,973,000 (151.43%)

-$3,836,000 (-219.88%)

$3,200,000 (215.61%)

Net Cash Flow from Financing

$7,936,000 (21.01%)

$6,558,000 (51.67%)

$4,324,000 (0%)

$0 (0%)

Net Cash Flow from Operations

-$8,827,000 (-3.45%)

-$8,533,000 (26.11%)

-$11,549,000 (-23.47%)

-$9,354,000 (-28.99%)

Net Cash Flow / Change in Cash & Cash Equivalents

$646,000 (32400.00%)

-$2,000 (99.98%)

-$11,061,000 (-79.74%)

-$6,154,000 (54.06%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$1,562,000 (-22.13%)

$2,006,000 (153.46%)

-$3,752,000 (-214.78%)

$3,269,000 (222.11%)

Capital Expenditure

-$25,000 (24.24%)

-$33,000 (60.71%)

-$84,000 (-21.74%)

-$69,000 (24.18%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$7,936,000 (21.01%)

$6,558,000 (51.67%)

$4,324,000 (0%)

$0 (0%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$1,349,000 (-3.23%)

$1,394,000 (-20.43%)

$1,752,000 (26.41%)

$1,386,000 (-28.45%)

Depreciation Amortization & Accretion

$91,000 (-14.15%)

$106,000 (3.92%)

$102,000 (34.21%)

$76,000 (11.76%)

MBOT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-234.00% (-42.60%)

-164.10% (-2.76%)

-159.70% (-163.53%)

-60.60% (-79.82%)

Return on Average Assets (ROAA)

-175.80% (-40.42%)

-125.20% (2.11%)

-127.90% (-133.39%)

-54.80% (-72.33%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

-356.70% (-31.14%)

-272.00% (40.95%)

-460.60% (-90.09%)

-242.30% (30.63%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.53 (1.79%)

-1.56 (6.07%)

-1.66 (64.74%)

-4.72 (11.68%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

5.37 (25.93%)

4.27 (30.94%)

3.26 (-12.11%)

3.71 (83.97%)

Debt to Equity Ratio (D/E)

0.71 (-16.71%)

0.85 (175.97%)

0.31 (85.54%)

0.17 (104.94%)

Earnings Per Share (EPS)

-0.73 (30.48%)

-1.05 (41.99%)

-1.81 (-13.84%)

-1.59 (-23.26%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-0.57 (32.62%)

-0.84 (47.57%)

-1.6 (-20.81%)

-1.33 (-28.49%)

Book Value Per Share (BVPS)

0.23 (-48.75%)

0.44 (-56.08%)

1 (-50.37%)

2.02 (-40.76%)

Tangible Assets Book Value Per Share (TABVPS)

0.39 (-52.70%)

0.82 (-37.90%)

1.31 (-44.30%)

2.36 (-36.11%)

Enterprise Value Over EBIT (EV/EBIT)

-2 (0.00%)

-2 (0.00%)

-2 (50.00%)

-4 (-33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.63 (3.94%)

-1.7 (-11.85%)

-1.52 (57.85%)

-3.6 (-41.50%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

2.37 (13.05%)

2.09 (-50.89%)

4.26 (-46.78%)

8 (-57.37%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$8,852,000 (-3.34%)

-$8,566,000 (26.36%)

-$11,633,000 (-23.45%)

-$9,423,000 (-28.33%)

Enterprise Value (EV)

$18,531,222 (2.59%)

$18,064,000 (-8.97%)

$19,843,790 (-51.01%)

$40,501,998 (74.74%)

Earnings Before Tax (EBT)

-$11,443,000 (-6.55%)

-$10,740,000 (18.44%)

-$13,168,000 (-16.40%)

-$11,313,000 (-23.38%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$11,352,000 (-6.75%)

-$10,634,000 (18.61%)

-$13,066,000 (-16.28%)

-$11,237,000 (-23.47%)

Invested Capital

$519,000 (-76.98%)

$2,255,000 (-58.33%)

$5,411,000 (187.36%)

$1,883,000 (-68.68%)

Working Capital

$3,359,000 (-18.77%)

$4,135,000 (-38.70%)

$6,745,000 (-51.46%)

$13,895,000 (-41.88%)

Tangible Asset Value

$6,031,000 (-27.57%)

$8,327,000 (-12.69%)

$9,537,000 (-43.12%)

$16,767,000 (-36.20%)

Market Capitalization

$18,964,222 (-1.23%)

$19,200,000 (-19.16%)

$23,750,790 (-55.45%)

$53,310,998 (8.85%)

Average Equity

$4,890,000 (-25.27%)

$6,543,750 (-20.64%)

$8,245,750 (-55.85%)

$18,674,750 (-31.37%)

Average Assets

$6,510,000 (-24.10%)

$8,576,750 (-16.67%)

$10,292,500 (-50.10%)

$20,625,750 (-28.57%)

Invested Capital Average

$3,208,250 (-18.74%)

$3,948,250 (38.11%)

$2,858,750 (-38.77%)

$4,668,750 (77.86%)

Shares

16,932,341 (44.63%)

11,707,317 (48.37%)

7,890,628 (11.01%)

7,108,133 (0.00%)